Filter your results
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma ProtuberansJournal of Investigative Dermatology, 2021, 141 (4), pp.761-769.e2. ⟨10.1016/j.jid.2020.06.039⟩
Journal articles
hal-03623658v1
|